School of Medicine
Showing 1-21 of 21 Results
-
Helen M. Blau
Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology and Professor, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsProf. Helen Blau's research area is regenerative medicine with a focus on stem cells. Her research on nuclear reprogramming and demonstrating the plasticity of cell fate using cell fusion is well known and her laboratory has also pioneered the design of biomaterials to mimic the in vivo microenvironment and direct stem cell fate. Current findings are leading to more efficient iPS generation, cell based therapies by dedifferentiation a la newts, and discovery of novel molecules and therapies.
-
Asuka Eguchi
Instructor, Microbiology & Immunology - Baxter Laboratory
BioAsuka Eguchi, PhD is an instructor working with Helen Blau, PhD at Stanford University. Her interests lie in understanding how cells sense and respond to genotoxic stress. Currently, she is developing therapeutic strategies to combat heart failure in Duchenne muscular dystrophy. Dr. Eguchi received her BS in Biology at the University of Alabama in Huntsville. As a graduate student, she developed an Artificial Transcription Factor library to interrogate transcriptional networks that control cell fate decisions under the mentorship of Aseem Ansari, PhD. During her postdoctoral research, she discovered that a telomere binding protein can rescue disease phenotypes of Duchenne muscular dystrophy in cardiomyocytes differentiated from patient-derived induced pluripotent stem cells. Dr. Eguchi is also developing gene therapies that address heart failure in Duchenne and Becker patients. She is a recipient of the Translational Research and Applied Medicine Award, the American Heart Association Postdoctoral Fellowship, and Muscular Dystrophy Association Development Grant.
-
Peter K. Jackson
Professor of Microbiology and Immunology (Baxter Labs) and of Pathology
Current Research and Scholarly InterestsCell cycle and cyclin control of DNA replication .
-
David McIlwain
Sr Res Scientist-Basic Life, Microbiology and Immunology - Baxter Labs
BioDr. McIlwain studies host-response to infectious disease using high dimensional single-cell and spatial proteomics tools. He trained for his Ph.D. at the University of Toronto exploring mouse biology using reverse genetics with renowned immunologist Dr. Tak W. Mak. His doctoral work yielded insights into alternative mRNA splicing and an important discovery about iRhom2 as a new factor controlling the production of inflammatory mediator TNF. As a post-doctoral fellow, Dr. McIlwain investigated host response to viral infection in animal models at the University of Dusseldorf in Germany before moving to Stanford University where along with Dr. Garry Nolan, he leads a team executing research contracted by the FDA’s medical countermeasures initiative to study emerging pathogens. This work includes mass cytometry (CyTOF) and spatial proteomic (CODEX) single-cell analysis of human and animal model influenza, Ebola, zika, and SARS-CoVs infections.
